必威体育登录手机Agilent Technologies' Thought Leader Award Supports Dr.Robert Gerszten's Work in Metabolomic Research at Massachusetts General Hospital

SANTA CLARA, Calif., Dec.18, 2012

必威体育登录手机Agilent Technologies Inc.(NYSE: A) today announced that Dr.必威体育登录手机Robert Gerszten, a recognized leader in cardiovascular research and biomarker discovery, has received an Agilent Thought Leader Award.

Dr.Gerszten is the director of clinical and translational research at Massachusetts General Hospital's Institute for Heart, Vascular and Stroke Care.The award will provide his laboratory with funding for personnel.必威体育登录手机Agilent will also provide technical and scientific expertise in metabolomics, automation and integrated biology in support of Dr.Gerszten's metabolite profiling study of well-phenotyped human populations, including his work with theFramingham Heart Study.

"Our goal is to identify new metabolites and proteins that mark disease activity, signal disease progression, and ultimately provide targets for therapeutic intervention," said Dr.Gerszten.必威体育登录手机"We are grateful that Agilent supports our research and is helping us in our quest to advance translational cardiology."

必威体育登录手机"Agilent is proud to support Dr.必威体育登录手机Gerszten's research in this pivotal project and further advance progress in the important field of cardiometabolic diseases," said Agilent CTO Darlene Solomon, the executive sponsor of the award."By providing support and cutting-edge technologies to leading translational researchers like Dr.Gerszten, we aim to facilitate innovative research and to progress the fields of metabolomics and integrated biology toward improved patient outcomes."

必威体育登录手机The Agilent Thought Leader Award program promotes fundamental advances by contributing philanthropic financial support, products and expertise to the research of thought leaders in the life sciences and chemical analysis.Information about previous recipients is available at必威体育登录手机www.dayu-jc.com/univ_relation/TLP/index.shtml.

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School.

---

必威体育登录手机About Agilent Technologies

必威体育登录手机Agilent Technologies Inc.(NYSE: A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications.The company's 20,500 employees serve customers in more than 100 countries.必威体育登录手机Agilent had revenues of $6.9 billion in fiscal 2012.必威体育登录手机Information about Agilent is available at必威体育登录手机www.dayu-jc.com.

# # #

For images related to this press release,
please visit the� ImageLibrary (Image #222)

Contact:

Eric Endicott
+1 408 553 2005
必威体育登录手机eric_endicott@agilent.com